<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01707979</url>
  </required_header>
  <id_info>
    <org_study_id>NIR</org_study_id>
    <nct_id>NCT01707979</nct_id>
  </id_info>
  <brief_title>NIR- and Multifrequent Impedance Spectroscopy on the Skin in Type 1 Diabetes</brief_title>
  <acronym>NIR</acronym>
  <official_title>NIR (Near Infrared)- Spectroscopy and Multifrequent Impedance Spectroscopy on the Skin to Detection of Sensory and Autonomic Neuropathy Among Patients With Type 1 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lise Tarnow</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Steno Diabetes Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to examine the suitability to detect diabetic neuropathy using NIR
      and impedance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to examine how suitable a hand-held measuring probe (DDD-probe) using
      NIR (near infrared light) as well as impedance (conductivity), is to detect early signs of
      diabetic neuropathy.

      The DDD-probe is put directly on the skin and is measuring by the use of light and impedance.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>near infrared spectroscopy</measure>
    <time_frame>one time</time_frame>
    <description>Near infrared (NIR) is measured by spectroscopy on the skin using the DDD probe</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Diabetic Neuropathy</condition>
  <arm_group>
    <arm_group_label>Diabetic neuropathy</arm_group_label>
    <description>Male participants, type1 diabetic with diabetic neuropathy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diabetes without neuropathy</arm_group_label>
    <description>Male participants, type1 diabetic without diabetic neuropathy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non diabetic control</arm_group_label>
    <description>Male participants, control group non diabetic</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Control group men without diabetes Type1 diabetic men without neuropathy complications Type
        1 diabetic men with neuropathy complications
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  men with type 1 diabetes (WHO criteria)

          -  age 35-50 years

          -  duration of diabetes &gt; 10 years

        Exclusion Criteria:

          -  P-creatinine&gt; 120 micromol/l

          -  other acute or chronic disease, or type of treatment that makes the patient unsuitable
             to participate, valuated by the investigator

          -  non intact skin on the measuring spots

          -  the patient is unable to understand the informed consent
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lise Tarnow, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Steno Diabetes Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Steno Diabetes Center</name>
      <address>
        <city>Gentofte</city>
        <zip>2820</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 25, 2012</study_first_submitted>
  <study_first_submitted_qc>October 15, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 16, 2012</study_first_posted>
  <last_update_submitted>October 15, 2012</last_update_submitted>
  <last_update_submitted_qc>October 15, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 16, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Steno Diabetes Center</investigator_affiliation>
    <investigator_full_name>Lise Tarnow</investigator_full_name>
    <investigator_title>Professor, Chief Physician</investigator_title>
  </responsible_party>
  <keyword>Near infrared light</keyword>
  <keyword>Diabetic neuropathy</keyword>
  <keyword>Sensory neuropathy</keyword>
  <keyword>Autonomic neuropathy</keyword>
  <keyword>Vagus</keyword>
  <keyword>Sudomotor function</keyword>
  <keyword>Monofilament</keyword>
  <keyword>Impedance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
    <mesh_term>Diabetic Neuropathies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

